Table 2 Measures, tools, domains and time-points for data collection for the POINT study
From: Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study
Domain | Measure | Baseline | T1 | T2 | T3 | Those who discontinue opioids |
|---|---|---|---|---|---|---|
Demographics | ||||||
     Age and sex | ✓ | ✕ | ✕ | ✕ | ✕ | |
     Marital status, employment, income | ✓ | ✓ | ✓ | ✓ | ✓ | |
     Educational attainment | ✓ | ✕ | ✕ | ✕ | ✓ | |
Pain | ||||||
     Pain | Brief pain Inventory (BPI) [49] | ✓ | ✓ | ✓ | ✓ | ✓ |
     Current chronic pain diagnosis, incident pain | ✓ | ✓ | ✓ | ✓ | ✕ | |
     Illness and disability history | ✓ | ✓ | ✓ | ✓ | ✕ | |
     Current physical disabilities | 6-items from the Washington Group [52] | ✓ | ✓ | ✓ | ✓ | ✓ |
Physical functioning | ||||||
     Physical functioning | ✓ | ✓ | ✓ | ✓ | ✓ | |
     Exercise | Exercise routine and how pain effects this | ✓ | ✓ | ✓ | ✓ | ✓ |
     Falls | Un-standardised questions examining falls | ✓ | ✕ | ✓ | ✓ | ✓ |
     Sleep | Medical Outcome Sleep scale (MOS) [54] | ✓ | ✓ | ✓ | ✓ | ✓ |
     Coping and pain | ✓ | ✓ | ✓ | ✓ | ✓ | |
Treatment | ||||||
     Past week use of prescription and OTC medications and dose | Self-complete 7 day medication diary | ✓ | ✓ | ✓ | ✓ | ✓ |
     Current prescribed medications and days of use in last month | ✓ | ✓ | ✓ | ✓ | ✓ | |
     Other treatments for chronic pain | ✓ | ✓ | ✓ | ✓ | ✓ | |
     Perceived effect of treatment | Patients’ Global Impression of Change scale (PGIC) [57] | ✓ | ✓ | ✓ | ✓ | ✕ |
     Beliefs about medicines | Beliefs about Medicines Questionnaires [58] | ✓ | ✕ | ✓ | ✓ | ✓ |
     Convenience of accessing medications | ✓ | ✕ | ✕ | ✕ | ✕ | |
     Side-effects of opioid medication | Pain Assessment and Documentation Tool (PADT) [59] | ✓ | ✓ | ✓ | ✓ | ✕ |
     Barriers to treatment | ✓ | ✓ | ✓ | ✓ | ✓ | |
     Reasons for discontinuance of opioids | ✕ | ✕ | ✕ | ✕ | ✓ | |
     Aberrant opioid medication-related behaviours | Opioid Related Behaviours In Treatment ORBIT scale [60] | ✓ | ✓ | ✓ | ✓ | ✕ |
     Opioid Difficulties | Prescribed Opioid Difficulties Scale (PODS) [61] | ✓ | ✕ | ✓ | ✓ | ✓ |
Quality of life | WHO-QoL-BRIEF [62] | ✓ | ✓ | ✓ | ✓ | ✓ |
Mental health | ||||||
     Mental health history | ✓ | ✕ | ✕ | ✕ | ✕ | |
     Depression | ✓ | ✓ | ✓ | ✓ | ✓ | |
     General Anxiety disorder | Patient Health Questionnaire (GAD) [65] | ✓ | ✓ | ✓ | ✓ | ✓ |
     Social Anxiety | Social Interaction Anxiety Scale (SIAS) [66] | ✓ | ✓ | ✓ | ✓ | ✓ |
     Social Phobia | Social Phobia Scale (SPS) [66] | ✓ | ✓ | ✓ | ✓ | ✓ |
     Agoraphobia | From the MINI International Neuropsychiatric Interview [67] | ✓ | ✓ | ✓ | ✓ | ✓ |
     Post-Traumatic Stress Disorder | PC-PTSD [68] | ✓ | ✓ | ✓ | ✓ | ✓ |
     Borderline personality disorder screener | Screener from the CIDI 3.0 [50] | ✓ | ✕ | ✕ | ✕ | ✕ |
     Child abuse | Childhood Trauma Questionnaire [69] | ✓ | ✕ | ✕ | ✕ | ✕ |
     Suicidality and self-harm | National Survey of Mental Health and Well-Being | ✓ | ✕ | ✓ | ✓ | ✓ |
     Social support | (SPQ), MOS Social Support [70] | ✓ | ✓ | ✓ | ✓ | ✓ |
     Locus of control | Multidimensional Health Locus of Control (B, C) [71] | ✓ | ✕ | ✓ | ✓ | ✓ |
Substance use | ||||||
     Lifetime and current drug use, illicit drug market | ✓ | ✓ | ✓ | ✓ | ✓ | |
     Drug and alcohol abuse and dependence | CIDI 3.0 [50] | ✓ | ✕ | ✕ | ✕ | ✓ |